Crossject is a French pharmaceutical company based in Dijon that develops needle-free injection devices. Its technology delivers medicines through the skin using a compact, single-use injector, and the company works on formulations of emergency and rescue treatments, including a needle-free version of midazolam for treating prolonged epileptic seizures. Crossject's customers and partners are mainly in the healthcare sector, such as hospitals, emergency services and pharmaceutical collaborators, and its work centres on making urgent medicines easier to give outside clinical settings.
The shares are listed on the Euronext Paris in France under the code ALCJ, and the price on this page is in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #490 of 625 on the Euronext Paris · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for France yet.
TrendWeak
17/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-25.7%
From 52-week high-50.8%
MomentumWeak
23/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-13.9%
6-month return-33.5%
12-month, skipping last month-45.8%
Stability (higher is calmer)Weak
32/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)51.2%
Worst drawdown, 1 year (smaller is calmer)-53.4%
LiquidityStrong
71/100
Trades actively.
See the numbers →
Avg daily value traded0.27M EUR
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for France when fundamentals data for this market is added. All France stocks.
52-wk range 1.100 – 2.695Daily closes, split-adjusted
Signals
50-day average1.371
200-day average1.782
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.068
Technical summary
Daily
Bearish
4 bullish · 3 neutral · 9 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
1.30
Bullish
EMA 10
1.31
Bullish
SMA 20
1.31
Bullish
EMA 20
1.32
Bullish
SMA 50
1.37
Bearish
EMA 50
1.38
Bearish
SMA 100
1.53
Bearish
EMA 100
1.51
Bearish
SMA 200
1.78
Bearish
EMA 200
1.68
Bearish
Oscillators (daily)
RSI (14)
49.49
Neutral
MACD (12, 26)
-0.02
Bearish
Momentum (12)
0.00
Neutral
Stochastic %K (14)
84.21
Bearish
Williams %R (14)
-15.79
Bearish
CCI (20)
1.68
Neutral
Pivot points (classic, last session)
S3
1.25
S2
1.27
S1
1.30
Pivot
1.31
R1
1.34
R2
1.35
R3
1.38
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
